AccuKnox provides an AI-powered Zero Trust Cloud-Native Application Protection Platform (CNAPP) securing applications across hybrid and multi-cloud environments. The platform integrates modules for CSPM, CWPP, ASPM, and specialized AI security to offer comprehensive security posture management and runtime defense. It delivers continuous compliance, workload protection, and threat detection from code to production across modern and traditional assets.

Aether Bio develops machine learning algorithms and proprietary robotic hardware to engineer enzymes for the production of complex biochemical compounds. This technology enables manufacturers to create novel products at significantly reduced costs by efficiently indexing and searching trillions of enzyme sequences.

The startup has developed a healthcare platform that utilizes clinical-grade sensors and machine learning to provide real-time risk assessments for respiratory infections and lifestyle diseases. By integrating patient histories and insurance claims data, the platform enables early detection of health conditions, facilitating timely intervention and management.

Alt is a financial services platform that facilitates the investment in alternative assets by providing a marketplace for trading collectibles and sports memorabilia. This approach enables investors to unlock liquidity and value from traditionally illiquid asset classes, addressing the challenge of accessing and monetizing these investments.

Atmosic Technologies designs low-power wireless solutions utilizing its Lowest Power Radio and Energy Harvesting technologies to significantly reduce battery consumption in IoT devices. This enables battery-free operation or extended battery life, addressing the maintenance challenges associated with traditional battery-dependent devices across various applications, including wearables and smart city infrastructure.

Atomos Space develops the Quark orbital transfer vehicle, utilizing autonomous rendezvous and high-thrust electric propulsion to provide in-space transportation and logistics services. The company addresses the need for satellite life-extension, relocation, and augmentation by offering precise cargo delivery and refueling solutions in low Earth and geostationary orbits.

August offers a retrofit smart lock that attaches to the interior side of existing single‑cylinder deadbolts, enabling keyless entry without replacing hardware. The lock connects via Bluetooth LE and an optional Wi‑Fi bridge to provide remote lock/unlock, auto‑lock, virtual guest keys, activity monitoring, and integration with voice assistants and smart‑home platforms. It includes DoorSense sensors, AES‑128/TLS encryption, and two‑factor authentication for secure access.

Basis provides a unified platform with specialized AI agents designed for accounting workflows across CAS, Tax, Audit, and Advisory practices. This platform streamlines firm operations, significantly saving time and improving efficiency for accounting professionals. By automating routine tasks, Basis empowers teams to concentrate on higher-value advisory and client service work.

Bionaut Labs develops microscale robots that utilize magnetic propulsion to navigate complex 3D trajectories within the human body, enabling localized delivery of biologics and small molecule therapies to targeted areas of severe brain disorders. This technology addresses the challenge of accessing deep anatomical regions for precise treatment and diagnostic detection, enhancing safety and efficacy in patient care.

Cajal Therapeutics develops novel small molecule and RNA medicines targeting iron homeostasis for systemic and neurologic diseases. Their therapies aim to restore iron balance, addressing conditions like anemias of inflammation and neurodegenerative disorders. The lead program focuses on an iron mobilizer to restore essential iron transport for cellular processes.

Canaery develops a neural interface that analyzes the scent fingerprint of objects to detect hazardous compounds. This technology provides a reliable method for identifying potential dangers in various environments, enhancing safety and risk management.

Cerevance utilizes its proprietary Nuclear Enriched Transcript Sort sequencing (NETSseq) platform to identify novel therapeutic targets for neurological diseases, including Parkinson's and Alzheimer's. The company develops cell type-specific therapies aimed at addressing the unmet medical needs associated with neurodegenerative and psychiatric disorders.

Cognitive Space provides an AI-powered platform for automated satellite constellation management, enabling operators to dynamically reschedule mission plans and optimize data collection in near real-time. The technology addresses the increasing complexity and operational demands of satellite operations, achieving up to 87% time savings per operator per week.

The startup develops deep-root technology that enhances soil quality by promoting the growth of deeper plant roots, which increases carbon sequestration capabilities. This method provides farmers with opportunities to earn carbon credits while improving crop resilience and soil health.

Cytovale has developed the IntelliSep test, an FDA-cleared diagnostic tool that analyzes the biomechanical properties of white blood cells from a standard blood draw to assess a patient's risk of sepsis within 8 minutes. This rapid detection addresses the critical challenge of timely diagnosis in sepsis, a condition that increases mortality by 8% for every hour treatment is delayed.

Delix Therapeutics develops neuroplastogens, a novel class of compounds that promote neuroplasticity to enhance brain health. Their approach targets neuropsychiatric conditions by repairing neural circuits and improving mental function through safe and fast-acting treatments.

DigiLens develops ARGO™ smartglasses using proprietary photopolymer materials and advanced waveguide optics to deliver high-resolution augmented reality experiences. This technology enables users to access and interact with digital information seamlessly in their physical environment, enhancing productivity and engagement.

This startup offers an automated microscope with features like inverted imaging, cell counting, and fluorescence. The system leverages cloud-based technology for image capture and management, providing researchers and pathologists with accurate images at a lower cost.

Eargo offers a fully in‑canal, rechargeable hearing aid that users can self‑fit at home using a guided online screening and a companion iOS/Android app. The device features adaptive sound processing with automatic environment detection, dynamic gain, and noise‑reduction, and it syncs hearing profiles and firmware updates via a secure cloud. It targets adults with mild‑to‑moderate high‑frequency hearing loss seeking a discreet, direct‑to‑consumer solution.

EnClear Therapies utilizes its proprietary EnTrega CSF Platform to deliver precision dosing of therapeutics directly to the central nervous system, minimizing severe side effects and peripheral toxicity. The company focuses on treating neuro-oncology and expanding into neurodegenerative, lysosomal storage, and autoimmune diseases, addressing the critical need for effective CNS disease management.

Esper operates a constellation of remote sensing satellites that utilize hyperspectral imaging to capture detailed spectral signatures of the Earth's surface. This technology provides precise data for monitoring methane emissions, assessing water quality, and optimizing agricultural practices, addressing the need for accurate environmental insights.

Genemod provides a cloud-based Laboratory Information Management System (LIMS) and Electronic Lab Notebook (ELN) that centralizes lab management, enabling real-time collaboration and efficient tracking of inventory, experiments, and protocols. This platform reduces operational costs by optimizing resource management and streamlining data entry, allowing scientists to focus on their research rather than administrative tasks.

Kebotix utilizes a self-driving lab that integrates cloud technologies, machine learning, and physical modeling to accelerate materials discovery and production. This approach addresses the lengthy and inefficient R&D processes in material innovation, enabling faster market entry for new products.

Yumanity Therapeutics develops next-generation immunotherapies that target cancer immune resistance through VISTA blocking mechanisms. The company focuses on addressing diseases caused by protein misfolding, enhancing the efficacy of cancer treatments.